GW&K Investment Management LLC raised its position in shares of Steris PLC (NYSE:STE) by 13.5% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 309,350 shares of the medical equipment provider’s stock after purchasing an additional 36,911 shares during the quarter. GW&K Investment Management LLC owned 0.37% of Steris worth $44,698,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Raymond James Trust N.A. lifted its position in shares of Steris by 2.8% during the 2nd quarter. Raymond James Trust N.A. now owns 2,658 shares of the medical equipment provider’s stock valued at $395,000 after buying an additional 72 shares in the last quarter. TrinityPoint Wealth LLC lifted its position in shares of Steris by 3.4% during the 2nd quarter. TrinityPoint Wealth LLC now owns 2,267 shares of the medical equipment provider’s stock valued at $336,000 after buying an additional 75 shares in the last quarter. CWM LLC lifted its position in shares of Steris by 130.9% during the 3rd quarter. CWM LLC now owns 187 shares of the medical equipment provider’s stock valued at $27,000 after buying an additional 106 shares in the last quarter. Parallel Advisors LLC lifted its position in shares of Steris by 7.6% during the 3rd quarter. Parallel Advisors LLC now owns 1,664 shares of the medical equipment provider’s stock valued at $240,000 after buying an additional 117 shares in the last quarter. Finally, Squar Milner Financial Services LLC lifted its position in shares of Steris by 225.9% during the 3rd quarter. Squar Milner Financial Services LLC now owns 176 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 122 shares in the last quarter. Institutional investors and hedge funds own 88.11% of the company’s stock.
Shares of STE stock traded up $0.65 during trading hours on Friday, reaching $145.84. 278,973 shares of the company traded hands, compared to its average volume of 477,181. Steris PLC has a 12-month low of $99.14 and a 12-month high of $156.66. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.41 and a quick ratio of 1.87. The company has a market cap of $12.38 billion, a P/E ratio of 29.82 and a beta of 0.88. The firm has a 50-day moving average price of $142.12 and a 200 day moving average price of $143.11.
Steris (NYSE:STE) last posted its quarterly earnings data on Monday, November 4th. The medical equipment provider reported $1.32 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.26 by $0.06. Steris had a return on equity of 14.28% and a net margin of 11.59%. The firm had revenue of $736.84 million for the quarter, compared to analysts’ expectations of $717.79 million. During the same period in the previous year, the firm earned $1.10 EPS. The business’s quarterly revenue was up 8.5% on a year-over-year basis. Sell-side analysts predict that Steris PLC will post 5.61 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Investors of record on Tuesday, November 26th will be issued a $0.37 dividend. The ex-dividend date is Monday, November 25th. This represents a $1.48 dividend on an annualized basis and a yield of 1.01%. Steris’s dividend payout ratio is presently 30.27%.
In related news, VP John Adam Zangerle sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of $142.15, for a total value of $142,150.00. Also, VP Renato Tamaro sold 2,065 shares of the business’s stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $153.15, for a total value of $316,254.75. The disclosure for this sale can be found here. 2.36% of the stock is currently owned by insiders.
Separately, ValuEngine cut Steris from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. Steris presently has an average rating of “Buy” and an average price target of $148.20.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
See Also: Which market index is the best?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.